![John Friend](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 150 $ al 31/05/2026
John E.
Friend is Chief Executive Officer & Director at Kazia Therapeutics Ltd. since 2024.
Formerly, Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018 and again from 2020 to 2021.
Chief Medical Officer at Druggability Technologies Holdings Ltd. (New Jersey).
Education includes undergraduate studies at Southern Methodist University and a doctorate from Robert Wood Johnson Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KAZIA THERAPEUTICS LTD 0,26 % | 18/03/2026 | 15.000.000 ( 0,26 % ) | 150 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Director Ejecutivo | 01/05/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 02/11/2021 |
| CELLECTAR BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 27/11/2018 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Director Técnico/Científico/I+D | 01/04/2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
